Role of Sleep and Sleep Disorders in Cardiometabolic Risk: a Review and Update

Artificial Intelligence in Sleep Medicine: The Dawn of a New Era

“…Randomized controlled trials have historically expressed skepticism regarding the efficacy of CPAP therapy in reducing cardiovascular events among patients with OSA, often yielding debated and disappointing results. 23 However, recent advancements and the utility of ML have introduced new hope for discerning the efficacy of CPAP by recognizing heterogeneity within the OSA population. A recent study utilized ML in the ISAACC trial dataset to identify subgroups exhibiting varied responses to CPAP therapy.…”